Alcohol-induced changes in stress-related neuropeptide circuitry
酒精引起的压力相关神经肽回路的变化
基本信息
- 批准号:10509944
- 负责人:
- 金额:$ 39.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAgonistAlcohol abuseAlcohol consumptionAlcohol dependenceAlcohol withdrawal syndromeAlcoholsAmericanAmygdaloid structureAnimal ModelAnxietyAnxiety DisordersArousalBehavior ControlBehavioralBiological MarkersBlood alcohol level measurementBrain InjuriesCell NucleusChronicClinicalConfocal MicroscopyConsumptionCorticosteroneCorticotropin-Releasing HormoneCorticotropin-Releasing Hormone ReceptorsDevelopmentDiagnosisEmotionsExhibitsExposure toFemaleFrequenciesGeneticGoalsHealthHigh PrevalenceImmunoelectron MicroscopyImmunohistochemistryIntakeInvestigationLinkMediatingMediatorMedicalModelingMolecularNeurobiologyNeuronsNeuropeptidesNorepinephrinePathway interactionsPhenotypePresynaptic TerminalsPrevalenceProsencephalonRattusReceptor SignalingRegulationRelapseReportingResearchResolutionRodentRoleSex DifferencesSignal TransductionSocietiesSourceStressSynapsesSystemTestingTracerViralWithdrawalWomanWorkalcohol abuse therapyalcohol consequencesalcohol effectalcohol exposurealcohol use disorderanxiety reductionanxiety-like behaviorbiological adaptation to stresschronic alcohol ingestioncostdrinkingdrinking behaviordrug of abuseexperimental studyfield studygenetic approachindividualized medicinelocus ceruleus structuremalemennerve supplyneural circuitneuropeptide Ynorepinephrine systemnovelopioid exposurepharmacologicreceptorsextraffickingtransmission process
项目摘要
ABSTRACT
Alcohol use disorders (AUDs) are serious medical conditions that afflict approximately 17 million Americans and
cost the U.S. $400 billion annually. Whereas men are diagnosed twice as frequently as women, a greater
vulnerability to adverse effects of alcohol occurs in women. Despite the sex differences in prevalence and effects
of AUD, the factors mediating the sex differences in the effects of alcohol use are not fully understood. Animal
models showed an escalation of alcohol drinking from baseline in male rodents while higher baseline drinking
was evident in female rodents. Withdrawal from chronic alcohol exposure induced a greater anxiety in male
compared to female. Research is needed on the neural circuitry underlying sex differences to advance the field
of alcohol neurobiology. AUD development involves the actions of critical neuropeptides in the central nucleus
of the amygdala (CeA), including corticotropin-releasing factor (CRF) and neuropeptide Y (NPY). CRF is an
excitatory stress neuropeptide that orchestrates stress responses, while NPY may act as an inhibitory or
excitatory neuropeptide. The CeA ubiquitously receives NPY-ergic afferents and is enriched with CRF neurons.
Alcohol exposure and withdrawal reduced the NPY signaling in the CeA while alcohol withdrawal increased CRF
levels in the CeA. We have shown that CRF neurons in the CeA project to the locus coeruleus (LC), a major
source of norepinephrine (NE) to the forebrain. The CRF CeA-LC pathway relays emotion-related information.
We propose that the specific NPY CRF-CeA LC pathway mediates sex differences in alcohol drinking and
anxiety-like behavior following withdrawal. The goal of the proposed work is to test the overarching hypothesis
that the specific NPY CRF-CeA LC-NE pathway mediates sex differences in alcohol drinking and anxiety-like
behavior during withdrawal. We will use a well-established rodent alcohol model, the intermittent-access ethanol
drinking (IED) paradigm. In this model, females initially consume more alcohol than males, while males escalate
intake, resulting in matched intake in males and females following 30 days of drinking. We will use IED to test
circuit and molecular mechanisms mediating alcohol effects on alcohol drinking and anxiety-like behavior. We
will integrate pharmacological, chemogenetics, behavioral, and cellular approaches including
immunohistochemistry, immunoelectron microscopy and tract tracing. AIM 1 tests the hypothesis that CRF-
containing neurons contacted by NPY in the CeA project to the LC-NE system, and that withdrawal from chronic
alcohol exposure alters the NPY-CRF synaptic organizations in male and female rats. Aim 2 tests the hypothesis
that Y1r agonism within the CRF-CeA neurons that project to LC will reverse the elevated alcohol drinking and
anxiety-like behavior during alcohol withdrawal in male and female rats. Elucidating sex differences in the
peptidergic interactions in the CeA that impact NE transmission under alcohol withdrawal, and the role of NPY
in modulating the LC-NE via the amygdalar CRF circuitry has significant clinical implications in developing
individualized therapies and novel targets for the treatment of AUDs.
摘要
酒精使用障碍(AUD)是一种严重的医疗状况,困扰着大约1700万美国人,
每年花费美国4000亿美元虽然男性被诊断出的频率是女性的两倍,
妇女容易受到酒精的不利影响。尽管在患病率和影响方面存在性别差异,
在AUD中,调节酒精使用影响的性别差异的因素尚未完全了解。动物
模型显示,在雄性啮齿动物中,饮酒量从基线增加,而基线饮酒量增加
在雌性啮齿类动物中很明显。长期酒精暴露的戒断会导致男性更大的焦虑
与女性相比。需要对性别差异背后的神经回路进行研究,以推动该领域的发展。
酒精神经生物学AUD的发展涉及中枢核团中关键神经肽的作用
包括促肾上腺皮质激素释放因子(CRF)和神经肽Y(NPY)。CRF是一个
兴奋性应激神经肽协调应激反应,而NPY可能作为抑制性或
兴奋性神经肽CeA普遍接受NPY能传入,并富含CRF神经元。
酒精暴露和酒精戒断减少了CeA中的NPY信号,而酒精戒断增加了CRF
在CeA的水平。我们已经表明,CRF神经元在CeA项目的蓝斑(LC),一个主要的
去甲肾上腺素(NE)的前脑来源。CRF CeA-LC通路传递情绪相关信息。
我们认为,特定的神经肽Y CRF-CeA LC通路介导了饮酒的性别差异,
戒断后的焦虑样行为拟议工作的目标是测试总体假设
特异性NPY CRF-CeA LC-NE通路介导了饮酒和焦虑样的性别差异。
撤退时的行为。我们将使用一个完善的啮齿动物酒精模型,即无障碍乙醇
饮酒(IED)模式。在这个模型中,女性最初比男性消费更多的酒精,而男性则逐步升级
摄入量,导致男性和女性在饮酒30天后摄入量匹配。我们会用简易爆炸装置
回路和分子机制介导酒精对饮酒和焦虑样行为的影响。我们
将整合药理学、化学遗传学、行为学和细胞学方法,包括
免疫组化、免疫电镜和束示踪。AIM 1测试了CRF-
含有神经肽Y接触的神经元投射到LC-NE系统,
酒精暴露改变了雄性和雌性大鼠的NPY-CRF突触组织。目标2检验假设
投射到LC的CRF-CeA神经元内的Y1 r激动将逆转饮酒量的增加,
雄性和雌性大鼠在酒精戒断期间的焦虑样行为。阐明性别差异,
CeA中影响酒精戒断时NE传递的肽能相互作用,以及NPY的作用
通过杏仁核CRF回路调节LC-NE具有重要的临床意义,
个体化治疗和治疗AUD的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Beverly Reyes其他文献
Beverly Reyes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 39.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 39.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 39.77万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 39.77万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 39.77万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 39.77万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 39.77万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 39.77万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 39.77万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 39.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)